| Course | HS140 Pharmacology |
|---|---|
| Unit | Unit 9 |
| Paper type | Special population brief |
| Length | About 460 words, 4 pages double-spaced |
| Format | APA 7 student paper |
| School | Purdue University Global |
| Program | BS in Health Science |
| Updated | October 2026 |
Free sample paper for HS140 Unit 9
Medicines and Breastfeeding: A Unit 9 Special Population Brief on How Drugs Reach Milk and How Clinicians Check
[Student Name]
Purdue University Global
HS140: Pharmacology
Unit 9 Special Population Brief
[Instructor Name]
[Date]
The examples are general; the clinical report, database and textbook cited are real, and no individual advice is given.
Why This Population Is Different
When a breastfeeding parent takes a medicine, a second person may receive some of it. Most drugs pass into milk in small amounts, and for most medicines breastfeeding can continue safely. But the amount and its effect depend on properties of the drug and on the infant, and a few medicines require caution or an alternative (Sachs et al., 2013).
What Decides How Much Reaches the Milk
Several properties matter (Lilley et al., 2023).
1. Protein binding. Drugs tightly bound to blood proteins stay in the blood and pass into milk less.
2. Molecular size. Very large molecules, such as insulin and many biologic antibodies, pass poorly.
3. Fat solubility. Fat-soluble drugs cross into milk more easily.
4. Half-life. Drugs that leave the parent's body quickly have less time to build up in milk.
5. Oral absorption by the infant. Some drugs that reach milk are not absorbed from the infant's gut.
What Decides the Effect on the Infant
The infant's age matters most. Newborns, and especially premature infants, have immature liver and kidney function, so drugs clear more slowly and can accumulate. An older infant who also eats solid food takes in less milk per kilogram.
A common measure is the relative infant dose: the dose the infant receives through milk, as a percentage of the parent's dose adjusted for weight. Values under about 10 percent are generally considered compatible with breastfeeding for most drugs, though the drug's own toxicity also matters.
The question is not whether a drug enters milk, since most do, but how much reaches the infant and what that amount can do.
Classes That Need Caution
Opioids, because some infants have developed sedation and breathing problems, especially with drugs that some parents convert to active forms quickly. Certain sedating medicines, for the same reason. Some cancer chemotherapy drugs and radioactive agents, which usually require stopping breastfeeding for a period. And a few drugs that reduce milk supply, such as some decongestants.
Where Clinicians Look
LactMed, a free database from the National Library of Medicine, summarizes evidence on drug levels in milk and effects on infants for hundreds of medicines (National Library of Medicine, 2006). Professional clinical reports, pharmacists and lactation specialists add judgment for individual cases. Product labels are less helpful, since they often advise caution without data.
Limits
This brief explains principles. Decisions for an individual parent and infant are made by their clinicians.
References
Lilley, L. L., Collins, S. R., & Snyder, J. S. (2023). Pharmacology and the nursing process (10th ed.). Elsevier.
National Library of Medicine. (2006). Drugs and lactation database (LactMed). National Institute of Child Health and Human Development.
Sachs, H. C., & Committee on Drugs. (2013). The transfer of drugs and therapeutics into human breast milk: An update on selected topics. Pediatrics, 132(3), e796-e809. https://doi.org/10.1542/peds.2013-1985
The Purdue Global HS140 Unit 9 instructions
Unit 9 centers on one special population, such as older adults, pregnancy, lactation, children or reduced kidney function, explaining which pharmacokinetic changes matter, which classes need caution and which references clinicians use. The brief is short, and instructors look for explanations grounded in pharmacokinetics rather than lists of drugs to avoid. Many prompts ask students to name the reference sources clinicians consult, which shows awareness of how decisions are made in practice. Individual advice is outside scope. A clear statement of the population's defining features opens most strong briefs. Naming the population's defining features in the first paragraph helps the reader follow the rest. The brief should stay general, leaving any decision about a particular parent to that person's clinicians.
How the HS 140 Unit 9 example is put together
The brief opens by explaining that a second person may receive the drug. Five numbered properties explain how much reaches the milk. A section on the infant explains why age and prematurity matter and defines the relative infant dose; the highlighted sentence restates the real clinical question. Classes needing caution follow: some opioids and sedating drugs, certain chemotherapy and radioactive agents and drugs that reduce supply. A section names LactMed, clinical reports, pharmacists and lactation specialists and notes the limits of product labels. A one-line limits section closes the brief. Each property is explained in one or two sentences, so the list can be read quickly by a busy clinician.
Reading the HS140 Unit 9 grading rubric
Special population briefs are commonly graded on accuracy of the pharmacokinetic principles, relevance to the chosen group, identification of higher-risk classes, knowledge of reference sources and clarity. Accuracy of principles usually carries the most weight. Relevance rewards explanations specific to the population rather than general pharmacology. Higher-risk classes earn credit when the reason for caution is given. Naming reliable references, and noting the weaknesses of others such as product labels, shows practical awareness. Plain language, organization by principle and accurate citations complete the grade. Briefs that simply list drugs to avoid usually score lower. Briefs that explain why product labels are less helpful than dedicated databases often earn extra credit.
HS140 Unit 9 help: mistakes that cost points
A common weakness is a brief that tells breastfeeding parents to avoid most medicines, which overstates the risk and is not supported by evidence. Another is listing properties without explaining how each affects transfer. Some students forget the infant's age, the most important factor in effect. Others cite product labels as the main source. Giving individual advice, such as whether a specific person should continue nursing, oversteps the brief. If your assigned population is different, perhaps older adults or reduced kidney function, send the prompt, and a brief can be prepared that explains which pharmacokinetic changes matter and where clinicians look. Mixing pregnancy and lactation principles without separating them also confuses readers.
Get an HS140 Unit 9 example written to your instructions
Let us know which population the Unit 9 prompt names, then send the instructions and rubric. From those, a custom special population brief citing current references is written and delivered within 24-48h. No fee applies to that first brief, and it keeps to explanation rather than dose changes throughout. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
More HS140 papers and BS in Health Science samples
- HS140 Unit 1: Drug Route Discussion Post
- HS140 Unit 2: Calcium Channel Blocker Class Profile
- HS140 Unit 3: Dosage Calculation Practice Set
- HS140 Unit 4: Stable Angina Drug Case
- HS140 Unit 5: Drug Interaction Analysis
- HS140 Unit 6: Medication Near Miss Seminar Reflection
- HS140 Unit 7: Asthma Inhaler Teaching Handout
- HS140 Unit 8: Hydroxychloroquine Monitoring Plan
- HS140 Unit 10: Medication Case Analysis
- HS111 Unit 9: Low Blood Sugar Patient Education Note
- HS499 Unit 9: Capstone Project Draft
- HS460 Unit 9: Seminar Reflection
HS140 Unit 9 questions, answered
Which population should I choose if the prompt lets me pick?
The one with the clearest pharmacokinetic story for the classes you know best. Older adults offer the most material and a well-known reference in the Beers Criteria. Kidney impairment is precise and numeric. Pregnancy involves the most uncertainty, since data are often limited, which can make for a thoughtful brief if you are comfortable writing about evidence gaps.
Should I mention pediatric patients?
Only if the prompt includes them or you choose them as your population. Children are not small adults: organ maturity, body composition and weight-based dosing all differ, and pediatric pharmacology is a large subject of its own. A brief that adds a sentence on children to an older-adult brief usually dilutes it rather than strengthening it.
Why were pregnancy letter categories replaced?
Because the A, B, C, D and X letters were widely read as a simple grading of risk, which they were not. In 2015 the FDA began replacing them with narrative sections on pregnancy, lactation and reproductive potential that summarize the available data. Citing the letters as current is a common error, and noting the change shows the brief uses up-to-date sources.
Where can I find a free HS140 Unit 9 sample paper?
This page has the complete Unit 9 special population brief on breastfeeding, explaining how drugs reach milk and which references clinicians use.
What is the relative infant dose?
The dose an infant receives through milk as a percentage of the parent's weight-adjusted dose. Values under about 10 percent are generally considered compatible for most drugs.